Anne Durnez

AZ Sint-Jan — Belgium

Medicine · Health Sciences

20h-index3.1kcitations48works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(18), Spondyloarthritis Studies and Treatments(13), Bone health and treatments(7), Systemic Lupus Erythematosus Research(5), Psoriasis: Treatment and Pathogenesis(5)

Publications48 total

Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial
RMD Open·2024· 2 citedOpen Access
Randomised trial of genetic testing and targeted intervention to prevent the development and progression of Paget’s disease of bone
Annals of the Rheumatic Diseases·2023· 12 citedOpen Access
Quantitative gait analysis in children with osteogenesis imperfecta: relationship between gait deviations and clinical features
Acta Orthopaedica Belgica·2022· 8 citedOpen Access
Characteristics of Early Paget's Disease in SQSTM1 Mutation Carriers: Baseline Analysis of the ZiPP Study Cohort
Journal of Bone and Mineral Research·2020· 15 citedOpen Access
Author response for "Characteristics of early Paget's disease in <i>SQSTM1</i> mutation carriers: Baseline analysis of the ZiPP study cohort"
2020Open Access
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent <i>SQSTM1</i> -mediated Paget’s disease of bone
BMJ Open·2019· 25 citedOpen Access
Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA
Lara D. Veeken·2019· 58 citedOpen Access
FRI0633 Which are the ultrasound lesions underlying dactylitis?
Annals of the Rheumatic Diseases·2017· 1 citedOpen Access
Bone Turnover Markers and Glucocorticoid Treatments
Biomarkers in disease·2017· 3 cited
Which are the ultrasound lesions underlying dactylitis
Annals of the Rheumatic Diseases·2017
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
Annals of the Rheumatic Diseases·2016· 114 cited
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club
Osteoporosis International·2016· 58 cited
THU0117 Low-Risk Patients Also Benefit from Remission Induction Treatment in Early Rheumatoid Arthritis: Week 52 Results from the Carera Trial
Annals of the Rheumatic Diseases·2015· 2 cited
OP0180 Remission Induction with Dmard Combinations and Glucocorticoids is not Superior to Remission Induction with MTX Monotherapy and Glucocorticoids: Week 52 Results of the High-Risk Group from the Carera Trial
Annals of the Rheumatic Diseases·2015· 3 cited
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
Arthritis Research & Therapy·2015· 42 citedOpen Access
Bone Turnover Markers and Glucocorticoid Treatments
Exposure and Health·2015· 1 cited
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
Annals of the Rheumatic Diseases·2014· 124 citedOpen Access
THU0137 Associated with A Glucocorticoid Bridging Scheme, Methotrexate is as Effective Alone as in Combination with Other DMARDS for Early Rheumatoid Arthritis, with Fewer Reported Side Effects: 16 Weeks Remission Induction Data from the Carera Trial
Annals of the Rheumatic Diseases·2014· 8 cited
THU0121 Comparison of MTX Therapy with or without A Moderate Dose Glucocorticoid Bridging Scheme in Early Rheumatoid Arthritis Patients Lacking Classical Poor Prognostic Markers: Week 16 Results from the Randomized Multicenter Carera Trial
Annals of the Rheumatic Diseases·2014· 4 cited
Fatigue in spondyloarthritis: a marker of disease activity. A cross-sectional study of 266 patients.
PubMed·2014· 20 cited
page 1 of 3Next →

Frequent Co-authors

Patrick Verschueren(13), René Westhovens(12), S. Paternotte(11), Tania Roskams(9), Rik Joos(9), V. Taelman(9), J. Vanhoof(9), E. Van Essche(9), Johan Joly(9), Laure Gossec(9), Chris Verslype(8), Diederik De Cock(8), Luk Corluy(8), C. Langenaken(8), F. Raeman(8), K. Vandevyvere(8), Elke Geens(8), Piet Geusens(8), J Remans(8), Bert Vander Cruyssen(8)